Coronavirus: Imperial College study says 1.15% patients die
Professor Lockdown and Imperial team say Covid-19 kills 1.15% of all patients – TWICE as high as the best guess of No10’s top scientists and the World Health Organization
- Experts have been baffled over the true mortality rate of the disease
- Imperial College London suggest its calculations are the most accurate to date
- It drew on a number of studies considered high quality to give an estimate
- The team said one in every 100 people who get infected with the virus die from it
Covid-19 kills around 1.15 per cent of all people who are infected, according to the latest projections by ‘Professor Lockdown’ and his team.
Neil Ferguson’s startling projection that up to 500,000 Britons could die of the life-threatening disease convinced ministers to put the UK into lockdown in March, on the basis that the virus has an infection fatality rate of around 1 per cent.
And now the Imperial College London epidemiologist, who stood down from SAGE after it was revealed he allowed his married lover to visit him at home during Britain’s lockdown, has issued a new report saying the fatality rate could be as high as 1.15.
Professor Ferguson and colleagues at Imperial boast their calculations — which say the equivalent of one in every 100 people who get infected with the virus die from it — are some of the most accurate to date.
However, their figure is more than double the best guess of top experts at the World Health Organization, who say the IFR stands at around 0.5 per cent. Even Number 10’s own scientific advisers are adamant it kills just one in 200 infected patients.
Top scientists have been baffled over the true mortality rate of the disease since the start of the pandemic in December, with estimates ranging from 0.01 per cent to 1.4 per cent.
To measure the death rate accurately, experts must know the number of infections. But early studies relied on flawed testing results, giving an inaccurate figure for how many people have had the disease, the Imperial team argue.
In the study, they admitted the death rate was much lower for younger people, saying it stands at around 0.1 per cent in the under 40s – the same as seasonal flu. And they added in low-income countries – which have younger populations – it could be as low as 0.23 per cent.
Experts have been baffled over the true mortality rate of the disease since the start of the pandemic in December, with estimates ranging from 0.01 per cent to 1.4 per cent
To understand how deadly Covid-19 is, scientists have to work out the ‘infection fatality rate’ (IFR).
The IFR estimates how many people die from the disease overall, including patients who don’t show any symptoms and may never get tested.
To measure IFR, scientists use official data on deaths. Most countries record a Covid-19 death as anyone who died after testing positive for the disease.
But not all the countries use the same measurements. The UK previously counted fatalities as anyone who died at any time after testing positive – which meant some victims were counted even if they recovered and were hit by a bus a month later.
But to calculate the IFR, scientists also must know exactly how many people have had the coronavirus — technically called SARS-CoV-2 — and this is not as easy to gauge.
Millions would have had the disease and not been tested due to a lack of capacity in the early days of the crisis. So measuring IFR is a difficult task, which is why estimates are so varied.
The only way academics can currently estimate how many people have had the coronavirus is through looking at how many people have developed antibodies to the virus.
Infected patients make antibodies — proteins made by the immune system to fight off pathogens in the future — weeks after their battle with the disease.
But not everyone who has Covid-19 develops antibodies if other parts of their immune system, such as T cells, clears the virus.
And studies have shown antibodies can wane over time, meaning many patients who were infected in the spring may now not be spotted by testing.
Just this week, a Government-funded study from Imperial found antibody levels in England declined by 26 per cent from June to September.
That’s why Professor Ferguson and colleagues claim estimates of the IFR to date are not as accurate as their own, which they say accommodate for these limitations.
After screening 175 studies, the researchers identified 10 antibody surveys they considered high quality because they had factored in the chances of antibody levels waning and inaccuracies in tests.
The most common reasons for excluding studies were a lack of reliable information on the accuracy of antibody test used in the study.
The Imperial study found IFR consistently increases as people get older, with the risk of death doubling approximately every eight years of age.
Because of this, the researchers claimed IFRs would be different in rich and poor countries. Low-income countries often have younger populations due to variations in life expectancies.
The IFR in a typical low-income country was calculated as 0.23 per cent.
But in high income countries, which have a greater concentration of elderly people, the IFR was estimated as 1.15 per cent.
This means more than one in every 100 people who get the coronavirus will die, including those who don’t show symptoms at all, are critically ill, and everyone in between.
The paper concluded: ‘Our estimates of the IFR of Covid-19 are consistent with early estimates and remain substantially higher than IFR estimates for seasonal influenza (less than 0.1 per cent in the US).
‘To the best of our knowledge, this is the first study accounting for seroreversion as part of IFR estimation as well as simultaneously accounting for uncertainty in serological test characteristics and delays from infection to death and seroconversion.’
Previously the World Health Organization — which published Imperial’s work — said its best guess on the IFR was 0.6 per cent.
Dr Maria Van Kerkhove said in August the estimate was based on data from several studies. At the start of the pandemic, when little was known about SARS-CoV-2, the agency feared the IFR was 3.4 per cent.
Dr Kerkhove said 0.6 per cent ‘may not sound like a lot but it is quite high’. It would suggest Covid-19 kills one in every 167 infected people.
It would also make the disease six times deadlier than seasonal influenza, which is estimated to kill 0.1 per cent of cases.
The Imperial team said of the studies they looked at, the IFR ranged from 0.33 per cent in Denmark to 2.3 per cent in Italy.
IFR estimates tend to be higher when researchers cannot account for everyone that has had the disease.
If they predict 100 people have had it, and 10 die, it would give an IFR of 10 per cent. But if they detect 1,000 people have it, and 10 die, it would give an IFR of 1 per cent.
Of the studies looked at by Imperial, antibody prevalence ranged from 1.6 per cent in Zurich, Switzerland to 12 per cent in New York State.
The overall estimated IFR does match that given by Cambridge University experts, who in late August gave a guess of 1.1 per cent.
They said it could be as high as 1.4 per cent after analysing Government data in the UK, showing that around eight per cent of the population had antibodies.
Previously a review of antibody surveillance studies by Stanford University experts in June suggested the coronavirus has a mortality rate of 0.25 per cent.
It reviewed 23 studies and showed variations in IFR across the world. Data showed Kobe — a city in Japan — had the lowest fatality rate (0.02 per cent), based on its having recorded 10 deaths among an estimated 41,000 cases.
At the other end of the scale was the 0.86 per cent estimate from Milan, where 1,459 deaths had occurred out of a projected 170,000 cases.
A more recent estimation from the review’s leader, Professor John Ioannidis is 0.27. The paper, published in the Bulletin of the World Health Organization last week, reviewed 61 studies from around the world.
London School of Hygiene and Tropical Medicine took a different approach, and studied the Covid-19 outbreak on the cruise ship the Diamond Princess.
Cruise ships are deemed an ideal environment to study because there is complete data available for everyone on board at the time.
The team found in March the fatality rate was 1.2 per cent — 13 deaths out of 712 cases — but the rate was adjusted to 0.5 per cent to reflect the entire population.
THe WHO believe Covid-19 kills 0.6 per cent of all patients or one in every 167. Although it sounds minimal, it means Covid-19 is six times deadlier than the flu and almost as twice as fatal as polio
Another German study in May which honed in on the small town of Gangelt put the rate at around 0.37 per cent.
Gideon Meyerowitz-Katz, of the University of Wollongong in Australia, estimated the IFR was 0.75 per cent. But it could be as low as 0.49 and as high as 1.01.
He and his colleague Dr Lea Merone, of James Cook University, searched online for IFR studies from around the world.
By comparison, the seasonal flu kills around 0.1 per cent of those it infects. Ebola kills around 50 per cent of all cases.
Mr Meyerowitz-Katz pointed to data from a separate study in Qatar that suggested it may be as low as 0.01 per cent — the equivalent of one death for every 10,000 cases. He said it was ‘by a very long way the lowest I’ve seen’.
The model was based on data about how the virus naturally spreads in a population and the results on results of mass swab and antibody tests.
Experts led by Dr Laith Abu Raddad found that the IFR was 0.01 per cent, which was ‘remarkable’, the researchers said.
But the estimate — that Covid-19 only kills 0.01 per cent of people it infects — cannot physically be true for the UK. It would mean the UK would only have suffered 6,600 deaths, for its population of 66million. The truth death toll stands between 45,000 and 60,000.
The IFR is different to the case-fatality ratio (CFR), another measures of how many people die of a disease which is based only on confirmed cases.
CFR is simply the number of deaths divided by diagnosed cases — which only represent a proportion of true infections.
The CFR ratio in Britain is around six per cent, given that 58,925 of the 965,340 people diagnosed have died.